Hemiasterlin is a potent antimitotic agent acting through inhibition of microtubule depolymerization. For this reason, the synthesis of new hemiasterlin derivatives has attracted a lot of interest in the organic chemistry community recently. In this paper, the synthesis and evaluation of the cytotoxicity of new simplified and racemic hemiasterlin derivatives were reported. All of the synthesized analogues were evaluated in vitro for cytotoxic activity against four human cell lines (KB, Hep-G 2 , LU and MCF 7 ). Most of these analogues possess a strong cytotoxic activity on two human cancer cell lines (KB and Hep-G 2 ) and very weak activity on LU and MCF 7 cell lines.
Hemiasterlin (1), a natural tripeptide isolated from marine sponges, consisting of three sterically congested amino acids. Hemiasterlin and its relatives are potent antimitotic agents that effectively inhibit tubulin polymerization by binding to the Vinca-peptide-binding sitein tubulin [1] [2] [3] 5] . The synthetic related analogue HTI-286 (2) displayed especially potent cytotoxicity against paclitaxel (Taxol TM ) resistant cancer cell lines in vitro and in vivo and is currently in clinical trials [4] [5] [6] [7] [8] . We synthesized new bioisosteric hemiasterlin analogues in which the indole moiety was replaced respectively by benzofurane and naphthalene groups (3, 4) showed potent cytotoxic activity against KB, Hep-G 2 and MCF 7 cancer cell lines ( Figure 1 ) [10] . Thus, in view of the previous work and in continuation of our synthetic interest in the new biological active hemiasterlin analogues [9, 10] , in the present article we investigated the synthesis and the cytotoxicity of new simplified hemiasterlin derivatives in which the methyl group in block C of hemiasterlin was replaced by hydrogen and the indol group in block A was also replaced respectively by benzofuran, naphthalene, 4-bromobenzene and 4-methoxybenzene groups. These new compounds will be prepared by coupling reaction between the racemic amino acids fragments 5a-d and enantiopure dipeptide 6 [9, 10] .
The synthesis of racemic amino acids 5a-d have been reported previously [9, 10] . First, corresponding aldehydes were converted to the azlactone and then which were converted to the α-keto acid by hydrolysis, and then were subsequently dimethylated through reductive amination to get the racemic amino acids. Next, the optical pure hemiasterlins 7 and 7' were synthesized from the coupling reaction of 5a, b with peptide 6 in the presence of benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) and N,N-diisopropylethylamine (DIEA), lead to the getting of two corresponding enantiomerically pure 7a, 7a' and 7b, 7b' after separation by column chromatography on silica gel of both diastereoisomers (Scheme 1). The structures of the synthesized compounds were determined based on analysis of spectroscopic data, including IR, MS, 1 H and 13 C NMR. According to the literature [7, 10] , we also assigned the stereochemistry of the diastereoisomers as S,S,S for compounds 7a, b and R,S,S for compounds 7a', b'.
Similarly, the coupling reaction of amino acids 5c, d to the peptide 6 in the presence of PyBOP and DIEA produced the racemic esters hemiasterlin derivatives 7c and 7d. Hydrolysis of esters 7c and 7d with LiOH in MeOH/H 2 O (3/1) at room temperature gave the corresponding racemic acid hemiasterlin derivatives 8c and 8d in moderate to good yields (Scheme 2).
The synthesized analogues were evaluated in vitro for their cytotoxic activity against four human cell lines (KB, Hep-G 2 , LU, and MCF 7 ) and the results were summarized in Table 1 . These results indicated that most of derivatives possess a potent cytotoxicity against KB and Hep-G 2 . Especially, the optically pure hemiasterlin 7a can be identified as the most promising compound with IC 50 values at 0.011µM against both KB and Hep-G 2 cell lines. On the other hand, the noticeable difference in the cytotoxicity of optically pure hemiasterlin and racemic hemiasterlin showed that the optically pure analogs exhibited high potent cytotoxic effects than corresponding racemic hemiasterlin and the new R,S,Sdiastereoisomers of hemiasterlin exhibited less potent cytotoxic effects than corresponding S,S,S-diastereoisomers of hemiasterlin. In conclusion, new simplified and racemic hemiasterlin derivatives were synthesized, in which the methyl group in block C of hemiasterlin were replaced by hydro and the indol groups in block A of hemisaterlin were also replaced respectively by benzofuran, naphthalene, 4-bromobenzene and 4-methoxybenzene groups. Most of these new analogues of hemiasterlin possess strong cytotoxic activities on two human tumor cell lines (KB and Hep-G 2 ).
Experimental
General: All reactions were performed in the appropriate ovendried glass apparatus and under nitrogen atmosphere. Unless otherwise stated, solvents and chemicals were obtained from commercial sources and used without further purification. Column chromatography was performed using silica gel (60Å, particle size 40-60 µm). NMR spectra were recorded on a Bruker Advance I (500 MHz). Chemical shifts (δ) are given in parts per million (ppm) and coupling constants (J) in hertz (Hz). High resolution mass spectrometry analysis (HRMS) was recorded on a Q-exactive or a Q-TOF2 instrument. IR analysis was recorded on Perkin Elmer Spectrum Two.
Preparation of compounds 7a, a', 7b, b': A solution of compound 5a or 5b (1.1 equiv) in DMF (5 mL/mmol) was added PyBOP (1.2 equiv) and DIEA (2.5 equiv) followed by compound 6 (1.0 equiv). The reaction mixture was stirred at room temperature for 12 h and then was partitioned between water and EtOAc. The aqueous phase was extracted with EtOAc and the combined EtOAc extracts were washed with brine, dried over MgSO 4 , filtered. The filtrate was concentrated under reduced pressure. The two diastereoisomers 7a and 7a' or 7b and 7b' were purified and separated by column chromatography on silica gel.
Preparation of compounds 7c, d:
A solution of compound 7c or 7d (1.1 equiv) in DMF (5 mL/mmol) was added PyBOP (1.2 equiv) and DIEA (2.5 equiv) followed by compound 6 (1.0 equiv). The reaction mixture was stirred at room temperature for 12 h and then was partitioned between water and EtOAc. The aqueous phase was extracted with EtOAc and the combined EtOAc extracts were washed with brine, dried over MgSO 4 , filtered. The filtrate was concentrated under reduced pressure. This material was purified by column chromatography on silica gel (n-hexane/EtOAc: 85/15) to obtain racemic 7c or 7d.
Preparation of compounds 8c, d:
A cold solution (0 °C) of compound 7c or 7d in a mixture of MeOH/H 2 O (3:1, 15 mL/mmol) was added LiOH (10 equiv). The cold bath was removed and the resulting mixture was stirred at room temperature for 10 h. The solvent was removed under reduced pressure and the residue was dissolved in a small amount of H 2 O. The aqueous solution was cooled to 0 °C and acidified to pH 5.5-6.0 with an aqueous HCl solution (2 M). Afterwards, the reaction mixture was extracted with EtOAc. The combined EtOAc extracts were washed with brine, dried over MgSO 4 , filtered, and the filtrate was concentrated under reduced pressure leading to the pure corresponding carboxylic acid derivatives 8c or 8d. 3-(benzofuran-3-yl)-3-methyl-2-(methylamino)butanamido)-3,3-dimethylbutanamido) 
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Colorless oil, 17% yield. IR (KBr) cm 2S)-2-(3-(4-bromophenyl)-3-methyl-2-(methylamino)butanamido)-3,3-dimethylbutanamido) (3H, s); 1.76-1.80 (1H, m); 1.54 (3H, s); 1.43 (3H, s) 170.0, 169.3, 167.3, 154.0,  138.4, 137.1, 126.4 (2xC), 126.3, 113.4 (2xC), 74.5, 60.1, 51.9,  40.6, 40.1, 35.1, 33.6, 32.3, 32.1, 26.3, 26.2 (2xC), 18.8, 18.1, 18.0 2S)-2-(3-(4-methoxyphenyl)-3-methyl-2-(methylamino)butanamido)-3,3-dimethylbutanamido)-2,5-dimethylhex-2 2S)-2-(3-(4-methoxyphenyl)-3-methyl-2-(methylamino)-butanamido)-3,3-dimethylbutanamido) Cell culture and cell viability assay: The synthesized compounds were evaluated for their cytotoxicity against four human cancer cell lines, including epidermoid carcinoma cell line (KB), hepatoma carcinoma cell line (HepG 2 ), breast carcinoma cell line (MCF7) and lung cancer cell line (LU) obtained from the American Type Culture Collection (USA) ATCC and used for cytotoxic evaluation. The cells were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 µg/mL streptomycin at 37°C in a humidified atmosphere (95% air and 5% CO 2 ). The exponentially growing cells were used throughout the experiments. The inhibitory effects of the compounds on the growth of the human cancer cell lines were determined by measuring the metabolic activity using a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay [13] . Briefly, human cancer cell lines (3×10 4 cells/mL) were treated for 3 days with a series of concentrations of the compounds (in DMSO): 0.125, 0.5, 2.0, 8.0, 32.0, and 128.0 µg/mL. After incubation, 0.1 mg MTT solution (50 µL of a 2 mg/mL solution) was added to each well, and the cells were then incubated at 37°C for 4 h. The plates were centrifuged at 1000 rpm for 10 min at room temperature, and the media were then carefully aspirated. Dimethylsulfoxide (150 µL) was added to each well to dissolve the formazan crystals. The plates were read immediately at 540 nm on a microplate reader (TECAN GENIOUS). All the experiments were performed three times, and the mean absorbance values were calculated. The results are expressed as the percentage of inhibition that produced a reduction in the absorbance by the treatment of the compounds compared to the untreated controls. A dose-response curve was generated, and the inhibitory concentration of 50% (IC 50 ) was determined for each compound as well as each cell line.
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